Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Colorcon
Moodys
Boehringer Ingelheim
Merck

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; quinapril hydrochloride and what is the scope of freedom to operate?

Hydrochlorothiazide; quinapril hydrochloride is the generic ingredient in three branded drugs marketed by Pfizer Pharms, Apotex Corp, Aurobindo Pharma, Invagen Pharms, Mylan, Sun Pharm Inds Ltd, and Lupin, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; quinapril hydrochloride. Seven suppliers are listed for this compound.

Recent Clinical Trials for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
LaborMed Pharma S.A.Phase 4
National Center for Research Resources (NCRR)Phase 4
Vanderbilt University Medical CenterPhase 4

See all HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE clinical trials

Recent Litigation for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Apotex, Inc. v. Mylan Pharmaceuticals, Inc.2012-04-20
Apotex, Inc. v. UCB, Inc.2012-04-20
Fleetwood Enterprises, Inc.2009-03-10

See all HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE litigation

Pharmacology for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Synonyms for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
C25H30N2O5.C7H8ClN3O4S2.Cl
LS-178473
SCHEMBL2526759
Paragraph IV (Patent) Challenges for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
ACCURETIC TABLET;ORAL hydrochlorothiazide; quinapril hydrochloride 020125

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 201356-003 Apr 20, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 078211-002 Mar 4, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 078211-003 Mar 4, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-001 Dec 28, 1999   Start Trial   Start Trial
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-003 Dec 28, 1999   Start Trial   Start Trial
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-002 Dec 28, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Moodys
Express Scripts
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.